Abstract
Quinine is used for the treatment of malarial infection, though not in common use. It is especially valuable for the parenteral treatment of severe illness owing to drug-resistant strains of Plasmodium falciparum. Quinine is also known to occasionally cause acute renal failure (ARF). Although quinine is listed in some reviews as a cause of acute interstitial nephritis, most cases of quinine-associated acute renal failure have been attributed to the hemolytic-uremic syndrome (HUS). Only two cases of acute renal failure due to acute interstitial nephritis associated with quinine have been reported [1, 2]. To our knowledge, there have been 6 reported cases of quinine-induced hepatic granuloma [3–8]. We report a case of quinine-induced acute interstitial nephritis (AIN) along with granulomatous hepatitis, both of which were confirmed on biopsy. A 50-year-old Nigerian man was admitted to the hospital with complaints of fever and general fatigue. He had been prescribed quinine as an antimalarial drug in a Nigerian hospital. The patient was febrile and showed nonoliguric ARF and liver dysfunction. In this case, liver injury showed gradual and spontaneous resolution after discontinuing quinine, and ARF resolved after treatment with oral prednisolone.
References
Lins RL, Verpooten GA, De Clerck DS, De Broe ME. Urinary indices in acute interstitial nephritis. Clin Nephrol. 1986;26:131–3.
Pawar R, Jacobs GH, Smith MC. Quinine-associated acute interstitial nephritis. Am J Kidney Dis. 1994;24:211–4.
Katz B, Weetch M, Chopra S. Quinine-induced granulomatous hepatitis. Br Med J (Clin Res Ed). 1983;286:264–5.
Mathur S, Dooley J, Scheuer PJ. Quinine induced granulomatous hepatitis and vasculitis. BMJ. 1990;300:613.
Perez JA Jr, Stryker J, Arsura EL, Hewitt JM. Probable quinine-induced hepatotoxicity. West J Med. 1994;160:59–60.
Horney E, Lagerstedt C, Wadenvik H. A case report. Thrombocytopenia and granulomatous hepatitis caused by quinine. Lakartidningen. 1996;93:361–4.
Hou M, Horney E, Stockelberg D, Jacobsson S, Kutti J, Wadenvik H. Multiple quinine-dependent antibodies in a patient with episodic thrombocytopenia, neutropenia, lymphocytopenia, and granulomatous hepatitis. Blood. 1997;90:4806–11.
Schlegel A. Factitious granulomatous hepatitis? Am J Med. 2004;116:500–1.
Laurence L. Brunton, John S. Lazo, Keith L. Parker. Chemotherapy of protozoal infection: malaria. Goodman and Gilman’s the pharmacological basis of therapeutics. 2006;1021–1047.
Kojouri K, Vesely SK, George JN. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med. 2001;135:1047–51.
Barsoum RS. Malarial acute renal failure. J Am Soc Nephrol. 2000;11:2147–54.
Markowitz GS, Perazella MA. Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chim Acta. 2005;351:31–47.
Praga M, Gonzalez E. Acute interstitial nephritis. Kidney Int. 2010;77:956–61.
Rossert J. Drug-induced acute interstitial nephritis. Kidney Int. 2001;60:804–17.
Glynne P, Salama A, Chaudhry A, Swirsky D, Lightstone L. Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome. Am J Kidney Dis. 1999;33:133–7.
Ramachandran R, Kakar S. Histological patterns in drug-induced liver disease. J Clin Pathol. 2009;62:481–92.
Drebber U, Kasper HU, Ratering J, Wedemeyer I, Schirmacher P, Dienes HP, Odenthal M. Hepatic granulomas: histological and molecular pathological approach to differential diagnosis–—a study of 442 cases. Liver Int. 2008;28:828–34.
Zakim D, Boyer T. Hepatology, A textbook of liver diseases. 4th ed. Philadelphia: Saunders; 2003.
Knobler H, Levij IS, Gavish D, Chajek-Shaul T. Quinidine-induced hepatitis. A common and reversible hypersensitivity reaction. Arch Intern Med. 1986;146:526–8.
Punukollu RC, Kumar S, Mullen KD. Quinine hepatotoxicity. An underrecognized or rare phenomenon? Arch Intern Med. 1990;150:1112–3.
Farver DK, Lavin MN. Quinine-induced hepatotoxicity. Ann Pharmacother. 1999;33:32–4.
Krishna S, White NJ. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin Pharmacokinet. 1996;30:263–99.
Silamut K, Molunto P, Ho M, Davis TM, White NJ. Alpha 1-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria. Br J Clin Pharmacol. 1991;32:311–5.
Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156:609–11.
Perazella MA, Markowitz GS. Drug-induced acute interstitial nephritis. Nat Rev Nephrol. 2010;6:461–70.
Laberke HG, Bohle A. Acute interstitial nephritis: correlations between clinical and morphological findings. Clin Nephrol. 1980;14:263–73.
Baker RJ, Pusey CD. The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant. 2004;19:8–11.
Conflict of interest
The authors have declared that no conflict of interest exists.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Katsuma, A., Shibata, M., Katsuki, T. et al. A case of acute interstitial nephritis and granulomatous hepatitis induced by ingesting quinine. CEN Case Rep 4, 76–80 (2015). https://doi.org/10.1007/s13730-014-0143-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-014-0143-0